Israel Had a 100% Protective mRNA Plague Vaccine in Mice Before Russian Lab Technician Died
4 Articles
4 Articles
With Corona and flu, mRNA technology is far from finished. Researchers have now developed a potential vaccine against lung plague – so far for mice, with three doses and under certain experimental conditions with allegedly 100 percent protective effect. In other experiments, however, only 37.5% of the animals survived. Developers are still thinking about resistant hospital germs, new pandemics and even bioweapons.
In first, Israeli researchers develop mRNA jab against pneumonic plague
In first, Israeli researchers develop mRNA jab against pneumonic plague | 13 July 2025 | In a research breakthrough, scientists from Tel Aviv University and the Israel Institute for Biological Research (IIBR) in Ness Ziona have developed the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. The vaccine against pneumonic plague is delivered via lipid nanoparticles like COVID-19 vaccines, and showed a 100 percent p…
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
